Antiretroviral Therapy and Viral Suppression Among Active Duty Service Members with Incident HIV Infection — United States, January 2012–June 2018
Shauna Stahlman(Defense Health Agency), Jason F. Okulicz(Gilead Sciences (United States)), Shilpa Hakre(Walter Reed Army Institute of Research), Todd Gleeson, Donald Shell, Paul T. Scott(Walter Reed Army Institute of Research), Jason M Blaylock, Brian K. Agan(Henry M. Jackson Foundation)
Cited by 4
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176
Identification of <i>Acinetobacter</i> Species and Genotyping of <i>Acinetobacter baumannii</i> by Multilocus PCR and Mass Spectrometry
|Journal of Clinical Microbiology|2006|164